Universal Chimeric Antigen Receptor-modified AT19 Cells for CD19+ Relapsed/Refractory Hematological Malignancies
Clinical trial NCT04796688 · UNKNOWN
Trial details
- NCT number
- NCT04796688
- Sponsor
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-10
- Primary completion
- 2023-03-10
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.